This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Positive results for interferon therapy
Drug boosts breast cancer TTP
Court finds AstraZeneca patients infringed
Velcade money-back scheme welcomed
Postmarketing studies “contribute little”
Doctors downplay bird flu risk
Magnesium stents yield good results
Wyeth litigation verdict overturned
Obama attacks US drug industry
Refractory RA: rituximab trumps anti-TNFs
No gain from clodronate
Voraxaze application withdrawn
« Previous
1
…
262
263
264
265
266
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: